References

Pathogenic nocardia: a diverse genus of emerging pathogens or just poorly recognized?

10.1371/journal.ppat.1008280 · 2020 · External reference

Prognosis and factors associated with disseminated nocardiosis: a ten-year multicenter study

10.1016/j.jinf.2022.05.029 · 2022 · External reference

Management dilemmas in nocardia brain infection

10.1097/qco.0000000000000782 · 2021 · External reference

Trimethoprim-sulfamethoxazole dosing and outcomes of pulmonary nocardiosis

10.1007/s15010-024-02323-9 · 2025 · External reference

How do I manage nocardiosis?

2021 · External reference

Structure, dynamics, and catalytic function of dihydrofolate reductase

10.1146/annurev.biophys.33.110502.133613 · 2004 · External reference

Nocardiosis in Quebec, Canada, 1988–2008

10.1111/j.1469-0691.2010.03306.x · 2011 · External reference

Susceptibility profiles of nocardia spp. to antimicrobial and antituberculotic agents detected by a microplate alamar blue assay

2017 · External reference

Antimicrobial susceptibility profiles and species distribution of medically relevant nocardia species: results from a large tertiary laboratory in Australia

10.1016/j.jgar.2019.06.018 · 2020 · External reference

Pathogenic Nocardia cyriacigeorgica and Nocardia nova evolve to resist trimethoprim-sulfamethoxazole by both expected and unexpected pathways

10.1128/aac.00364-18 · 2018 · External reference

Directed evolution of trimethoprim resistance in Escherichia coli

10.1111/j.1742-4658.2007.05801.x · 2007 · External reference

Characterization of trimethoprim resistant E. coli dihydrofolate reductase mutants by mass spectrometry and inhibition by propargyl-linked antifolates

10.1039/c6sc05235e · 2017 · External reference

Structure-guided functional studies of plasmid-encoded dihydrofolate reductases reveal a common mechanism of trimethoprim resistance in Gram-negative pathogens

10.1038/s42003-022-03384-y · 2022 · External reference

Properties of brodimoprim as an inhibitor of dihydrofolate reductases

1984 · External reference

Construction of a pair of practical nocardia-escherichia coli shuttle vectors

10.7883/yoken.jjid.2007.45 · 2007 · External reference

XDS

10.1107/s0907444909047337 · 2010 · External reference

Solving structures of protein complexes by molecular replacement with phaser

10.1107/s0907444906045975 · 2007 · External reference

Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in phenix

10.1107/s2059798319011471 · 2019 · External reference

Highly accurate protein structure prediction with AlphaFold

10.1038/s41586-021-03819-2 · 2021 · External reference

Current developments in coot for macromolecular model building of electron Cryo-microscopy and crystallographic data

10.1002/pro.3791 · 2020 · External reference

FoldScript: a web server for the efficient analysis of AI-generated 3D protein models

10.1093/nar/gkaf326 · 2025 · External reference

Massive overproduction of dihydrofolate reductase in bacteria as a response to the use of trimethoprim

10.1111/j.1432-1033.1987.tb10664.x · 1987 · External reference

Opposing effects of target overexpression reveal drug mechanisms

10.1038/ncomms5296 · 2014 · External reference

Cloning, expression, and characterization of Mycobacterium tuberculosis dihydrofolate reductase

10.1016/s0378-1097(04)00038-2 · 2004 · External reference

Kinetic and chemical mechanism of the dihydrofolate reductase from Mycobacterium tuberculosis

10.1021/bi1016843 · 2010 · External reference

Folate pathway disruption leads to critical disruption of methionine derivatives in Mycobacterium tuberculosis

10.1016/j.chembiol.2014.04.009 · 2014 · External reference

10.1128/aac.00717-23

10.1128/aac.00717-23 · External reference

Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?

10.1093/rheumatology/kep101 · 2009 · External reference

Rational exploration of 2,4-Diaminopyrimidines as DHFR inhibitors active against Mycobacterium abscessus and Mycobacterium avium, two emerging human pathogens

10.1021/acs.jmedchem.4c01594 · 2024 · External reference

Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs 1

10.1006/jmbi.1999.3328 · 2000 · External reference

Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: crystallographic evidence

10.1021/bi962337c · 1997 · External reference

Deciphering key features in protein structures with the new ENDscript server

10.1093/nar/gku316 · 2014 · External reference

10.7554/elife.50509

10.7554/elife.50509 · External reference

Trimethoprim resistance of dihydrofolate reductase variants from clinical isolates of Pneumocystis jirovecii

10.1128/aac.01161-13 · 2013 · External reference